Ontarget Investigators , Yusuf S., Teo KK, Pogue J. et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med2008;358:1547-59.
2.
Parving HH, Persson F., Lewis JB, Lewis EJ, Hollenberg NK; AVOID Study Investigators.Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med2008;358:2433-46.
